Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Rockefeller Foundation has announced $3 million in new funding for (G.h) – a first-of-its-kind, open-source platform for scientific pandemic data. This will enable it to expand its international partnerships and modernize the global effort around coordinated pandemic prevention, surveillance, and response. enables access to real-time, anonymized health data on infectious disease outbreaks, for the first time. Image credit: © Shutterstock

Co-developed by researchers and engineers at the Department of Biology, University of Oxford and Boston Children’s Hospital, USA, enables access to real-time, anonymized health data on infectious disease outbreaks, for the first time. The G.h database already holds over 100 million detailed, verified, harmonized, and de-identified SARS-CoV-2 case records from more than 130 countries: the most comprehensive repository of COVID-19 data in the world.

Dr Moritz Kraemer, Co-Founder of and Associate Professor at the Department of Biology, University of Oxford, commented: ‘'s mission is to organize the world’s infectious disease data to enable more rapid responses to them. So far we have been focused on the initial phase of disease outbreaks, such as COVID-19 and monkeypox, and we will now be able to broaden our international partnerships and build our analytical tools to improve wider outbreak detection and response.’

What began as a volunteer-driven data science project at the outset of the COVID-19 pandemic, has grown into a scalable and flexible data platform that sets a new standard for open, granular, and standardized case data. This information will be a vital resource for epidemiologists and public health leaders to model and mitigate the spread of emerging infectious diseases.

Read the full story on the University of Oxford website. 

Similar stories

Interview with Diagnostics in Tropical and Infectious Diseases(DiTi) award recipient Dr Christopher Chew

Global Health research at Oxford University and its partners is broad reaching, bringing significant impact across all academic disciplines of medicine, the physical and life sciences, social sciences and humanities. The Diagnostics in Tropical and Infectious Disease (DiTi) award aims to strengthen the long-term partnership between Oxford University and Mahidol University by establishing partnerships and supporting collaborative projects to develop diagnostic devices for tropical and infectious diseases, with the goal of driving more translational research initiatives in global health. Read this interview from award winner Dr Chris Chew.